Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New approaches in vaccine development.

Claude Leclerc1

  • 1Unité de Biologie des Régulations Immunitaires, Institut Pasteur, 28 rue du Docteur Roux, Cedex 15 75015, Paris, France. cleclerc@pasteur.fr

Comparative Immunology, Microbiology and Infectious Diseases
|June 24, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TLR9 activation is required for cytotoxic response elicited by baculovirus capsid display.

Immunology·2022
Same author

IL-17 suppresses the therapeutic activity of cancer vaccines through the inhibition of CD8<sup>+</sup> T-cell responses.

Oncoimmunology·2020
Same author

The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients.

Cancer immunology, immunotherapy : CII·2020
Same author

Persistence of Integrase-Deficient Lentiviral Vectors Correlates with the Induction of STING-Independent CD8<sup>+</sup> T Cell Responses.

Cell reports·2019
Same author

Design, Synthesis, and Immunological Evaluation of a Multicomponent Construct Based on a Glycotripeptoid Core Comprising B and T Cell Epitopes and a Toll-like Receptor 7 Agonist That Elicits Potent Immune Responses.

Journal of medicinal chemistry·2018
Same author

Mitochondrial reactive oxygen species regulate the induction of CD8<sup>+</sup> T cells by plasmacytoid dendritic cells.

Nature communications·2018

Developing new vaccines for diseases like AIDS and malaria is crucial. Modern vaccinology can accelerate this by leveraging advances in molecular biology and immunology to find new targets and strategies.

Area of Science:

  • Vaccinology
  • Immunology
  • Molecular Biology

Background:

  • Vaccines have significantly reduced infectious disease impact, eradicating smallpox and controlling others.
  • Infectious diseases remain a leading global cause of mortality, necessitating new vaccine development.
  • Existing vaccine efficacy and safety improvements are also a high priority.

Purpose of the Study:

  • To explore novel approaches for vaccine candidate discovery.
  • To discuss the application of advanced molecular and immunological knowledge in vaccinology.
  • To identify new antigenic targets and vaccination strategies.

Main Methods:

  • Leveraging pathogen genome data for antigenic target identification.
  • Utilizing insights into immune system function for vaccine design.

Related Experiment Videos

  • Integrating modern molecular biology and immunology techniques.

    • Main Results:

    • Potential for discovering new antigenic targets through genomic analysis.
    • Enhanced understanding of immune responses to inform vaccine strategies.
    • Framework for developing next-generation vaccines.

    Conclusions:

    • Modern vaccinology requires innovative methods beyond traditional approaches.
    • Advances in molecular biology and immunology offer powerful tools for vaccine development.
    • Continued research is essential for creating vaccines against challenging diseases like AIDS and malaria.